title: Spatial and temporal distribution of CD44 and osteopontin in fracture callus.
abstract: The multifunctional adhesion molecule CD44 is a major cell-surface receptor for hyaluronic acid (HUA). Recent data suggest that it may also bind the ubiquitous bone-matrix protein, osteopontin (OPN). Because OPN has been shown to be a potentially important protein in bone remodelling, we investigated the hypothesis that OPN interactions with the CD44 receptor on bone cells participate in the regulation of the healing of fractures. We examined the spatial and temporal patterns of expression of OPN and CD44 in healing fractures of rat femora by in situ hybridisation and immunohistochemistry. We also localised HUA in the fracture callus using biotinylated HUA-binding protein. OPN was expressed in remodelling areas of the hard callus and was found in osteocytes, osteoclasts and osteoprogenitor cells, but not in cuboidal osteoblasts which were otherwise shown to express osteocalcin. The OPN signal in osteocytes was not uniformly distributed, but was restricted to specific regions near sites where OPN mRNA-positive osteoclasts were attached to bone surfaces. In the remodelling callus, intense immunostaining for CD44 was detected in osteocyte lacunae, along canaliculi, and on the basolateral plasma membrane of osteoclasts, but not in the cuboidal osteoblasts. HUA staining was detected in fibrous tissues but little was observed in areas of hard callus where bone remodelling was progressing. Our findings suggest that OPN, rather than HUA, is the major ligand for CD44 on bone cells in the remodelling phase of healing of fractures. They also raise the possibility that such interactions may be involved in the communication of osteocytes with each other and with osteoclasts on bone surfaces. The interactions between CD44 and OPN may have important clinical implications in the repair of skeletal tissues.
authors.affiliation: Department of Orthopaedic Surgery, Chiba University School of Medicine, Japan.
authors.forename: M
authors.initials: M
authors.lastname: Yamazaki
authors.forename: F
authors.initials: F
authors.lastname: Nakajima
authors.forename: A
authors.initials: A
authors.lastname: Ogasawara
authors.forename: H
authors.initials: H
authors.lastname: Moriya
authors.forename: R J
authors.initials: RJ
authors.lastname: Majeska
authors.forename: T A
authors.initials: TA
authors.lastname: Einhorn
mesh_terms: D000818:Animals; D016723:Bone Remodeling / Q000502:physiology; D002146:Bony Callus / Q000473:pathology*; D005264:Femoral Fractures / Q000473:pathology*; D017102:Fracture Healing / Q000502:physiology*; D018960:Hyaluronan Receptors / Q000032:analysis*; D006820:Hyaluronic Acid / Q000032:analysis; D008297:Male; D010010:Osteoclasts / Q000473:pathology; D010011:Osteocytes / Q000473:pathology; D053495:Osteopontin; D051381:Rats; D017207:Rats, Sprague-Dawley; D012795:Sialoglycoproteins / Q000032:analysis*
chemical_list: D018960:Hyaluronan Receptors; D012795:Sialoglycoproteins; C506897:Spp1 protein, rat; D053495:Osteopontin; D006820:Hyaluronic Acid